Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Iridium Communications
IRDM
$5.29B
| $3.65M | ﹤0.01% |
91,183
-10,135
| -10% | -$394K |
|
|
CIM
1777
Chimera Investment
CIM
$1B
| $3.64M | ﹤0.01% |
80,524
-28,099
| -26% | -$1.17M |
|
1778
Matsons
MATX
$6.18B
| $3.64M | ﹤0.01% |
56,868
-32,895
| -37% | -$2.15M |
|
1779
Ryanair
RYAAY
$31.3B
| $3.64M | ﹤0.01% |
84,035
+76,320
| +989% | +$3.45M |
|
1780
Federal Signal
FSS
$7.83B
| $3.63M | ﹤0.01% |
90,256
-29,141
| -24% | -$1.2M |
|
1781
Renasant Corp
RNST
$3.91B
| $3.63M | ﹤0.01% |
90,680
-11,193
| -11% | -$477K |
|
1782
TD Synnex
SNX
$20.2B
| $3.63M | ﹤0.01% |
29,797
+8,173
| +38% | +$1M |
|
1783
Axsome Therapeutics
AXSM
$10.9B
| $3.62M | ﹤0.01% |
53,717
+18,681
| +53% | +$1.12M |
|
1784
Editas Medicine
EDIT
$442M
| $3.6M | ﹤0.01% |
63,594
-40,923
| -39% | -$1.51M |
|
|
PCH
1785
DELISTED
PotlatchDeltic
PCH
| $3.6M | ﹤0.01% |
67,811
-301
| -0.4% | -$17.3K |
|
1786
Nektar Therapeutics
NKTR
$2.58B
| $3.59M | ﹤0.01% |
13,958
+12,790
| +1,095% | +$3.54M |
|
1787
Kinsale Capital Group
KNSL
$8.51B
| $3.59M | ﹤0.01% |
21,785
-1,424
| -6% | -$235K |
|
|
GWB
1788
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.58M | ﹤0.01% |
109,252
+8,548
| +8% | +$283K |
|
1789
Brighthouse Financial
BHF
$3.5B
| $3.57M | ﹤0.01% |
78,476
+27,564
| +54% | +$1.3M |
|
|
IBDO
1790
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $3.56M | ﹤0.01% |
136,586
+133,532
| +4,372% | +$3.49M |
|
|
SAFM
1791
DELISTED
Sanderson Farms Inc
SAFM
| $3.55M | ﹤0.01% |
18,892
-3,124
| -14% | -$526K |
|
1792
Knowles
KN
$3.34B
| $3.55M | ﹤0.01% |
179,668
-8,200
| -4% | -$167K |
|
1793
PUT
BioMarin Pharmaceuticals
BMRN
$12.4B
| $3.54M | ﹤0.01% |
+42,400
| New | +$3.36M |
|
|
TGNA
1794
DELISTED
TEGNA Inc
TGNA
| $3.54M | ﹤0.01% |
188,454
-44,951
| -19% | -$882K |
|
1795
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $3.53M | ﹤0.01% |
30,600
| – | – |
|
|
MDP
1796
DELISTED
Meredith Corporation
MDP
| $3.53M | ﹤0.01% |
81,281
+19,134
| +31% | +$679K |
|
|
JBTM
1797
JBT Marel
JBTM
$6.39B
| $3.51M | ﹤0.01% |
24,626
-16,307
| -40% | -$2.27M |
|
|
BECN
1798
CALL
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.51M | ﹤0.01% |
65,900
-48,600
| -42% | -$2.71M |
|
1799
iShares California Muni Bond ETF
CMF
$4.62B
| $3.51M | ﹤0.01% |
56,018
+54,978
| +5,286% | +$3.44M |
|
1800
MillerKnoll
MLKN
$1.67B
| $3.51M | ﹤0.01% |
74,360
-15,077
| -17% | -$683K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.